By contrast, an earlier study examining data from the PCa Prevention Trial, an RCT assessing whether Finasteride reduced PCa risk, found markers of systemic inflammation (in this case c‐reactive protein) or lower levels of soluble receptors that bind inflammatory cytokines (such as TNF and IL‐6) did increase BPH risk.156. Here, IL6 is linked to posterior cortical atrophy.